Forte Biosciences, Inc. (FBRX)
NASDAQ · Healthcare
Forte Biosciences, Inc. Shareholder Equity 2016–2019
Forte Biosciences, Inc. annual shareholder equity history from 2016 to 2019. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Forte Biosciences, Inc. shareholder equity as of December 31, 2019: -4.8M, a 547.96% increase year-over-year.
- Forte Biosciences, Inc. shareholder equity for 2019 were -4.8M, a 547.96% increase from 2018.
- Forte Biosciences, Inc. shareholder equity for 2018 were -736,000, a 101.04% decrease from 2017.
- Forte Biosciences, Inc. shareholder equity for 2017 were 71.1M, a 157.13% decrease from 2016.
- Forte Biosciences, Inc. shareholder equity for 2016 were -124.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Forte Biosciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2019 | $-5 |
| 2018 | $-1 |
| 2017 | $71 |
| 2016 | $-124 |
Forte Biosciences, Inc. Shareholder Equity — FAQ
Forte Biosciences, Inc. (FBRX) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FBRX's shareholder equity history?
The chart and table above show Forte Biosciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.